I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 14 studies | 22% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 11 studies | 23% ± 7% | |
| endothelial cell | 7 studies | 26% ± 9% | |
| glutamatergic neuron | 6 studies | 38% ± 21% | |
| mucosal invariant T cell | 6 studies | 32% ± 10% | |
| epithelial cell | 6 studies | 32% ± 13% | |
| retinal cone cell | 6 studies | 20% ± 4% | |
| ciliated cell | 5 studies | 26% ± 8% | |
| CD8-positive, alpha-beta T cell | 5 studies | 21% ± 4% | |
| interneuron | 5 studies | 30% ± 20% | |
| oligodendrocyte precursor cell | 5 studies | 23% ± 9% | |
| mature NK T cell | 4 studies | 19% ± 2% | |
| neuron | 4 studies | 23% ± 7% | |
| GABAergic neuron | 4 studies | 41% ± 16% | |
| astrocyte | 4 studies | 30% ± 7% | |
| oligodendrocyte | 4 studies | 22% ± 4% | |
| gamma-delta T cell | 4 studies | 23% ± 4% | |
| basal cell | 3 studies | 30% ± 17% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 16% ± 1% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 19% ± 2% |
